Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Biovation Limited
Download detailed PDF Members: Biovation is a leading European protein engineering company specialising in antibody and protein engineering, with particular emphasis on antibody-based therapeutics. The Company is focused on the generation of antibodies and proteins which are non-immunogenic in man. The focus for protein therapeutics is the generation of clinically safe and effective molecules which are tolerated by the human immune system. Biovation's DeImmunisationTM technology has been successfully applied to generate over a dozen therapeutic antibodies ("DeImmunised antibodies") and has been the subject of eight corporate relationships to date. Biovation has also developed BiodisplayTM technology for the isolation of new antibodies from human antibody libraries. These antibodies are then subjected to DeImmunisation in order to generate therapeutic antibodies. The same human antibody libraries are being applied for proteomics in order to rapidly interrogate and profile proteins in human cells and tissues.
This page has been viewed 680 times since April 2007, the link to the organisation's website has been followed 140 times Recent Search Terms used to find this page: biovation limited | Biovation limited | biovation limited | Biovation Limited | Biovation Limited | Biovation Limited | biovation | biovation limited | biovation | BIOVATION LIMITED | . Search for more companies in Aberdeen Search for more companies in Scotland This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Biovation Limited | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|